Keyphrases
Clinical Outcomes
100%
Crohn's Disease
100%
Clinical Biomarkers
100%
Endoscopic Outcomes
100%
Trough Concentration
100%
Ustekinumab
100%
Endoscopic Response
35%
Clinical Remission
28%
C-reactive Protein
28%
Tumor Necrosis Factor Antagonist
21%
Serum Levels
14%
Intolerant
14%
Index Score
14%
Clinical Response
14%
Anti-drug Antibodies
14%
Fecal Calprotectin
14%
Patient Cohort
14%
Maintenance Therapy
14%
Steroid-free
14%
Endoscopic Remission
14%
Harvey-Bradshaw Index
14%
Simple Endoscopic Score for Crohn's Disease
14%
Effective Treatment
7%
Prospective Longitudinal Study
7%
Area under the Curve
7%
Interleukin-12 (IL-12)
7%
Interleukin-23 (IL-23)
7%
Real Patients
7%
Response Reduction
7%
P40 Subunit
7%
Biomarker Normalization
7%
Reduction Response
7%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Crohn's Disease
100%
Ustekinumab
100%
Remission
42%
C Reactive Protein
28%
Tumor Necrosis Factor
21%
Calgranulin
14%
Drug Antibody
14%
Interleukin 12
7%
Interleukin 23
7%
Medicine and Dentistry
Biological Marker
100%
Patient with Crohn's Disease
100%
Ustekinumab
100%
C Reactive Protein
28%
Tumor Necrosis Factor
21%
Crohn's Disease
14%
Faecal Calprotectin
14%
Maintenance Therapy
14%
Drug Antibody
14%
Interleukin 12
7%
Interleukin 23
7%